Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells

• Autores principales: Tzu-En Huang (Autor), Yi-Ning Deng (Autor), Jui-Ling Hsu (Autor), Wohn-Jenn Leu (Autor), Elena Marchesi (Autor), Massimo L. Capobianco (Autor), Paolo Marchetti (Autor), Maria Luisa Navacchia (Autor), Jih-Hwa Guh (Autor), Daniela Perrone (Autor), Lih-Ching Hsu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy in adults and accounts for 85-90% of all primary liver cancer. Based on the estimation by the International Agency for Research on Cancer in 2018, liver cancer is the fourth leading cause of cancer death globally. Dihydroarte...